C. Ordoñez, A. García, D. Burbano, Julian Chica, C. Orlas, F. Ariza, R. Manzano, Camilo J Salazar, S. Carvajal
{"title":"Performance of Multiple Massive Transfusion Definitions in Trauma Patients","authors":"C. Ordoñez, A. García, D. Burbano, Julian Chica, C. Orlas, F. Ariza, R. Manzano, Camilo J Salazar, S. Carvajal","doi":"10.5005/jp-journals-10030-1275","DOIUrl":null,"url":null,"abstract":"Introduction: Massive transfusion (MT) is defined as the administration of ≥ 10 U of packed red blood cells (PRBCs) in 24 hours. Alternative definitions have been proposed which have not been compared regarding mortality or multiorgan failure (MOF). The objective is to compare the discriminative ability of proposed definitions of MT concerning mortality and MOF. Materials and methods: Patients with trauma team activation in a level I trauma hospital of Cali, Colombia, between 2015 and 2017 were included. Demographics and trauma characteristics were evaluated. The following MT definitions were measured: ≥ 50 U of total blood products in 24 hours (MT50-24), ≥ 6 U of PRBCs in 6 hours (MT6-6), ≥ 10 U of PRBCs in 6 hours (MT10-6), a combination of MT10-24 plus MT6-6 (MTcombi), ≥ 5 U of PRBC in 4 hours (MT5-4), ≥ 4 U of PRBC in 1 hour (MT4-1), and the critical administration threshold (CAT) which is 3 U of PRBCs in 1 hour. The operative characteristics were calculated for each definition. Multiorgan failure was defined as a sequential organ failure assessment (SOFA) score of ≥ 6 points. Results: We included 394 subjects. A total of 266 (67%) received at least 1 unit of PRBCs in the first 24 hours, from which trauma mechanism was penetrating in 84.6%; 86.8% were male, with a median [interquartile range (IQR)] age of 29 (22–38) years and injury severity score (ISS) of 25 (25–29). A positive ABC score for massive transfusion score was positive in 87.2%. Sensitivity and specificity were as follows: multiorgan failure: MT10-24 18.6% and 98.2%, MT6-6 34.3% and 91.3%, MTcombi 38.2% and 91.3%, MT5-4 38.2% and 92.2%, and MT4-1 48% and 78.4%. Mortality: MT10-24 40.6% and 92.2%, MT6-6 62.7% and 82.6%, MTcombi 64.4% and 80.6%, MT5-4 61% and 81.1% and MT4-1 71.1% and 68.6%. Conclusion: All definitions showed an association with a higher risk of mortality and MOF, generally with low sensitivity but high specificity. The MT definition of ≥ 10 PRBCs in 24 hours should be revised.","PeriodicalId":74395,"journal":{"name":"Panamerican journal of trauma, critical care & emergency surgery","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Panamerican journal of trauma, critical care & emergency surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10030-1275","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Introduction: Massive transfusion (MT) is defined as the administration of ≥ 10 U of packed red blood cells (PRBCs) in 24 hours. Alternative definitions have been proposed which have not been compared regarding mortality or multiorgan failure (MOF). The objective is to compare the discriminative ability of proposed definitions of MT concerning mortality and MOF. Materials and methods: Patients with trauma team activation in a level I trauma hospital of Cali, Colombia, between 2015 and 2017 were included. Demographics and trauma characteristics were evaluated. The following MT definitions were measured: ≥ 50 U of total blood products in 24 hours (MT50-24), ≥ 6 U of PRBCs in 6 hours (MT6-6), ≥ 10 U of PRBCs in 6 hours (MT10-6), a combination of MT10-24 plus MT6-6 (MTcombi), ≥ 5 U of PRBC in 4 hours (MT5-4), ≥ 4 U of PRBC in 1 hour (MT4-1), and the critical administration threshold (CAT) which is 3 U of PRBCs in 1 hour. The operative characteristics were calculated for each definition. Multiorgan failure was defined as a sequential organ failure assessment (SOFA) score of ≥ 6 points. Results: We included 394 subjects. A total of 266 (67%) received at least 1 unit of PRBCs in the first 24 hours, from which trauma mechanism was penetrating in 84.6%; 86.8% were male, with a median [interquartile range (IQR)] age of 29 (22–38) years and injury severity score (ISS) of 25 (25–29). A positive ABC score for massive transfusion score was positive in 87.2%. Sensitivity and specificity were as follows: multiorgan failure: MT10-24 18.6% and 98.2%, MT6-6 34.3% and 91.3%, MTcombi 38.2% and 91.3%, MT5-4 38.2% and 92.2%, and MT4-1 48% and 78.4%. Mortality: MT10-24 40.6% and 92.2%, MT6-6 62.7% and 82.6%, MTcombi 64.4% and 80.6%, MT5-4 61% and 81.1% and MT4-1 71.1% and 68.6%. Conclusion: All definitions showed an association with a higher risk of mortality and MOF, generally with low sensitivity but high specificity. The MT definition of ≥ 10 PRBCs in 24 hours should be revised.
大量输血(MT)被定义为24小时内输入≥10u的红细胞(红细胞)。关于死亡率或多器官衰竭(MOF),已经提出了几种不同的定义,但尚未进行比较。目的是比较提出的MT关于死亡率和MOF的定义的判别能力。材料与方法:纳入2015 - 2017年在哥伦比亚卡利某一级创伤医院开展创伤小组活动的患者。评估人口统计学和创伤特征。测量以下MT定义:24小时总血制品≥50 U (MT50-24), 6小时PRBC≥6 U (MT6-6), 6小时PRBC≥10 U (MT10-6), MT10-24 + MT6-6 (MTcombi), 4小时PRBC≥5 U (MT5-4), 1小时PRBC≥4 U (MT4-1),以及关键给药阈值(CAT),即1小时PRBC≥3 U。计算每个定义的手术特征。多器官衰竭定义为顺序器官衰竭评估(SOFA)评分≥6分。结果:纳入394名受试者。266例(67%)患者在24小时内接受了至少1单位的红细胞,其中84.6%的患者创伤机制穿透;86.8%为男性,中位年龄为29(22-38)岁,损伤严重程度评分(ISS)为25(25 - 29)岁。大量输血ABC评分阳性占87.2%。多器官衰竭:MT10-24分别为18.6%和98.2%,MT6-6分别为34.3%和91.3%,MTcombi分别为38.2%和91.3%,MT5-4分别为38.2%和92.2%,MT4-1分别为48%和78.4%。死亡率:MT10-24分别为40.6%和92.2%,MT6-6分别为62.7%和82.6%,MTcombi分别为64.4%和80.6%,MT5-4分别为61%和81.1%,MT4-1分别为71.1%和68.6%。结论:所有的定义都显示与较高的死亡率和MOF风险相关,通常具有低敏感性但高特异性。24小时内红细胞≥10个的MT定义应予修订。